Valuation Metrics and Recent Changes
As of 13 March 2026, Balaji Amines trades at ₹1,047.55, slightly above its previous close of ₹1,042.70. The stock’s 52-week range spans from ₹905.15 to ₹1,946.00, indicating significant volatility over the past year. The company’s P/E ratio currently stands at 23.56, a figure that has contributed to its reclassification from very expensive to expensive in valuation terms. This adjustment reflects a marginal improvement in price attractiveness, though the stock remains priced at a premium relative to historical averages.
The price-to-book value ratio is 1.80, signalling that the market values the company at nearly twice its book value. This is consistent with the specialty chemicals sector’s tendency to command premium valuations due to growth prospects and technological differentiation. However, when compared to peers such as Navin Fluorine International and Himadri Speciality Chemical, which exhibit P/E ratios of 56.74 and 32.37 respectively, Balaji Amines appears more reasonably priced.
Peer Comparison Highlights
Within the specialty chemicals industry, Balaji Amines’ valuation metrics position it as relatively less expensive than several key competitors. For instance, Navin Fluorine International and Acutaas Chemicals are rated as very expensive, with P/E ratios exceeding 56 and EV/EBITDA multiples above 34 and 46 respectively. Himadri Speciality Chemical and Sumitomo Chemical also maintain very expensive valuations, with P/E ratios above 32 and EV/EBITDA multiples near 24 and 28.
In contrast, Balaji Amines’ EV/EBITDA ratio of 14.03 is significantly lower than these peers, suggesting a more attractive entry point for investors seeking exposure to the specialty chemicals sector without the elevated premium. Deepak Nitrite and Aarti Industries, rated as fair in valuation, trade at higher P/E ratios of 37.22 and 43.58 respectively, further underscoring Balaji Amines’ comparatively moderate valuation.
Our latest weekly pick is out! This Large Cap from Steel/Sponge Iron/Pig Iron delivered with target price and complete analysis. See what makes this week's selection special!
- - Latest weekly selection
- - Target price delivered
- - Large Cap special pick
Financial Performance and Returns Analysis
Balaji Amines’ return profile over various time horizons reveals a mixed picture. Year-to-date, the stock has declined by 6.35%, underperforming the Sensex’s 10.78% fall. Over the past year, the stock has dropped 15.67%, contrasting with the Sensex’s positive 2.71% gain. Longer-term returns are more striking; over five years, Balaji Amines has declined 41.03%, while the Sensex has appreciated 49.70%. Over a decade, however, the stock has delivered a remarkable 675.96% return, significantly outpacing the Sensex’s 207.61% rise.
This divergence highlights the stock’s cyclical nature and sector-specific challenges, including raw material price fluctuations and regulatory pressures. The recent valuation adjustment to expensive from very expensive may reflect market caution amid these headwinds, despite the company’s underlying growth potential.
Profitability and Efficiency Metrics
Balaji Amines’ return on capital employed (ROCE) stands at 9.66%, while return on equity (ROE) is 7.75%. These figures indicate moderate profitability relative to capital invested and shareholder equity. The dividend yield of 1.05% offers a modest income component for investors, though it is not a primary attraction given the company’s growth orientation.
Enterprise value to capital employed (EV/CE) is 1.88, and EV to sales is 2.34, suggesting that the market values the company at nearly twice its sales and close to twice its capital base. These multiples are consistent with an expensive valuation but remain below the very expensive ratings of several peers.
Mojo Score and Rating Update
MarketsMOJO’s proprietary scoring system assigns Balaji Amines a Mojo Score of 28.0, categorising it as a strong sell. This represents a downgrade from the previous sell rating as of 1 September 2025. The downgrade reflects deteriorating fundamentals and valuation concerns, signalling caution for investors considering new positions.
The company’s small-cap market capitalisation further adds to the risk profile, as smaller companies often exhibit higher volatility and liquidity constraints compared to large-cap peers.
Is Balaji Amines Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Valuation Context and Investor Implications
The shift in Balaji Amines’ valuation grade from very expensive to expensive suggests a modest improvement in price attractiveness, but the stock remains priced at a premium relative to many benchmarks. Investors should weigh this against the company’s moderate profitability metrics and recent underperformance relative to the broader market.
Given the specialty chemicals sector’s inherent cyclicality and competitive pressures, the current valuation may reflect a cautious market stance. While Balaji Amines offers a more affordable entry point than some of its very expensive peers, the strong sell rating and small-cap status advise prudence.
Long-term investors may find value in the company’s decade-long outperformance, but near-term risks and valuation concerns temper enthusiasm. Monitoring quarterly earnings, margin trends, and sector developments will be critical to reassessing the stock’s attractiveness going forward.
Conclusion
Balaji Amines Ltd’s recent valuation adjustment highlights a subtle shift in market perception, moving the stock into a more attractive price range relative to its historical and peer benchmarks. However, the strong sell Mojo Grade and modest profitability metrics underscore ongoing challenges. Investors should carefully consider these factors alongside sector dynamics before committing capital.
In summary, while the stock’s valuation has improved slightly, it remains an expensive proposition within the specialty chemicals space, warranting a cautious approach amid mixed financial signals and competitive pressures.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
